Treatment options for HER2-expressing colorectal cancer: updates and recent approvals
Colorectal cancer is a leading cause of cancer-related mortality worldwide. Approximately 3–5% of colorectal tumors harbor human epidermal growth factor receptor ( HER2 ) amplification which is associated with a higher incidence of intracranial metastasis and overall worse outcomes. In the setting o...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-01-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359231225037 |